⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27010186 | 0.83 | TSHR (0.31) | — | |
| SCHEMBL24316191 | 0.77 | — | — | |
| SCHEMBL24316037 | 0.73 | TSHR (0.36) | — | |
| SCHEMBL24316055 | 0.68 | CYP2D6 (0.31) | — | |
| SCHEMBL25093222 | 0.67 | — | — | |
| SCHEMBL27010284 | 0.67 | — | — | |
| SCHEMBL24315839 | 0.66 | USP2 (0.41) | — | |
| SCHEMBL24316197 | 0.64 | OPRM1 (0.32) | — | |
| SCHEMBL21298888 | 0.62 | TSHR (0.33) | — | |
| SCHEMBL15170716 | 0.62 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081925-A1 | TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 | C4 THERAPEUTICS, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| US-9585884-B2 | Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2017-03-07 | — | — | US | disclosed |